More companies wanted to join AstraZeneca supply deal, according to one of the Philippines’ presidential advisers. One of the Philippines’ presidential advisers on Monday said that more companies wanted to join the agreement between private sector and the Philippine government in securing a supply of AstraZeneca COVID-19 vaccine. This, after senior officials announced that the … Read more
AstraZeneca COVID-19 Vaccine would undergo stringent clinical trial in the Philippines, according to Galvez. COVID-19 Vaccine Czar Secretary Carlito Galvez Jr. on Saturday said that AstraZeneca would undergo stringent clinical trial for its COVID-19 vaccine in the Philippines. This, as he allayed fears on potential local use of AstraZeneca COVID-19 vaccine amidst questions on its … Read more
The Philippine government would also buy AstraZeneca COVID-19 vaccine too, according to DOST official. An official from the Department of Science and Technology (DOST) on Friday said that the Philippine government would also buy doses of AstraZeneca COVID-19 vaccine. This, after senior officials said that the country had secured and would get 2.6 million doses … Read more
The Philippines had secured 2.6 million doses of AstraZeneca COVID-19 vaccine, according to senior officials. Senior officials on Friday said that the Philippines would get 2.6 million doses of AstraZeneca COVID-19 vaccine under the country’s first supply deal for a COVID-19 vaccine. Joey Concepcion, a government business adviser representing the private sector, said that the … Read more
An “additional study” on its COVID-19 vaccine was needed, according to the head of AstraZeneca. The head of British vaccine manufacturer AstraZeneca on Thursday said that an “additional study” on its COVID-19 vaccine was needed after questions popped up over the protection it offered. However, in a report on Agence France-Presse, the additional testing was … Read more
COVID-19 vaccine can be “90% effective”, according to AstraZeneca. AstraZeneca on Monday said that its COVID-19 vaccine was 70 percent effective in pivotal trials and could be up to 90 percent effective. This, as it gave the world’s fight against COVID-19 pandemic a third new weapon that can be easier to distribute, cheaper to make, … Read more